Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FTC
MedTech
FTC outlines antitrust case against Edwards' JenaValve deal
In its opening statement, the FTC said Edwards would control the only two potential TAVR systems designed to treat aortic regurgitation.
Conor Hale
Nov 25, 2025 3:10pm
FTC tells Novo that Metsera offer may violate US merger law
Nov 5, 2025 4:26pm
FTC aims to stop Edwards' acquisition of JenaValve
Aug 7, 2025 11:33am
Sanofi CEO does not rule out future Pompe BD despite FTC moves
Jan 10, 2024 3:37pm
Illumina sets a date to divest Grail
Dec 18, 2023 11:12am
Sanofi scraps Maze deal after FTC throws up antitrust obstacles
Dec 12, 2023 6:00am